Leslie Isenegger and Paul Tyahla, Reputation & Risk Management, were featured in the "Pricing Front & Center" article in the January 2018 edition of PharmaVOICE.
Leslie says, "Our health system faces a unique challenge: the innovation of precision medicines and therapies for previously untreatable diseases has rapidly outpaced the models we use to pay for them".
This content is repurposed from PharmaVoice.
